Advertisement

Topics

Search Results for "Http Dx Doi Org 10 1002 Adma 201104290"

07:32 EST 24th February 2017 | BioPortfolio

Matching Channels

Freiberg Infraction

Freiberg's disease is an osteochondrosis of the metatarsal head, most commonly occurring in young athletes older than 12 years who perform on their toes in either sprinting or jumping activities...

Pediculosis - louse (lice) treatment

   To view our most recent articles on Lice Treatment please go to: http://www.bioportfolio.com/news/article/987636/Pediculosis-Louse-Lice-Treatment.html    

Pediculosis - louse (lice) infestation

   To view our most recent article on Lice Infestation please go to: http://www.bioportfolio.com/news/article/987568/Pediculosis-Louse-Lice-Infestation.html 

Pediculosis - louse (lice) diagnosis

   To view our most recent articals on Lice Diagnosis please view: http://www.bioportfolio.com/news/article/987588/Pediculosis-Louse-Lice-Diagnosis.html

G-protein-coupled receptors (GPCRs)

GPCRs are a large family of cell surface receptors that respond to a variety of external signals. Binding of a signaling molecule to a GPCR results in G protein activation, which in turn triggers th...

Matching News

ADMA to buy US Biotest plant and fix problems that derailed RI-002

ADMA Biologics has agreed to buy production assets from the CMO whose manufacturing deficiencies saw the US FDA reject its lead candidate, RI-002, last year.

BRIEF-Biotest to sell US therapy business to ADMA Biologics Inc.

* Biotest to sell US therapy business to ADMA Biologics, Inc. receiving approximately 50% of the shares of ADMA Biologics, Inc

BRIEF-ADMA Biologics to acquire certain assets from Biotest Pharmaceuticals Corp

* ADMA Biologics to acquire certain assets from Biotest Pharmaceuticals Corporation and become a vertically integrated commercial plasma products company

ADMA Biologics Reports Third Quarter 2016 Results

RAMSEY, N.J., Nov. 10, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plas...

ADMA Biologics to Acquire Certain Assets from Biotest Pharmaceuticals Corporation and Become a Vertically Integrated Commercial Plasma Products Company

ADMA to secure: Ownership and control of U.S. based Immune Globulin manufacturing facility FDA licensed products portfolio with immediate and on-going commercial sales $40M in Equity/Debt Fin...

Biotech Forum Daily Digest: Notable Trial Failures; NASH Continues To Be Tough Space To Solve; Spotlight On ADMA Biologics

Capricorn Drops Cenderitide to Focus on Cell and Exosome Therapies

Capricor Therapeutics is dropping further development of its Phase II-stage heart failure drug, Cenderitide, and is terminating its licence agreement with the Mayo Clinic for the natriuretic peptide r...

ADMA to Acquire Mfg. & Therapy Assets

Will buy certain assets from Biotest Pharmaceuticals and become a vertically integrated commercial plasma products company

Matching PubMed Articles

Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD.

Elevated plasma concentrations of the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA) have been observed in respiratory conditions such as asthma and cystic fibrosi...

Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia.

Cognitive deficits are a core feature of schizophrenia. Previous studies have shown that plasma asymmetric dimethylarginine (ADMA), an endogenous inhibitor of the nitric oxide synthase, was increased ...

Comprehensive analysis of the L-arginine/L-homoarginine/nitric oxide pathway in preterm neonates: potential roles for homoarginine and asymmetric dimethylarginine in foetal growth.

L-Arginine (Arg) and L-homoarginine (hArg) are precursors of nitric oxide (NO), a signalling molecule with multiple important roles in human organism. In the circulation of adults, high concentrations...

ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiography.

Asymmetric dimethylarginine (ADMA) is a competitive inhibitor of the nitric oxide (NO)-synthase and a biomarker of endothelial dysfunction (ED). ED plays an important role in the pathogenesis of contr...

Serum ADMA and arginine levels predict micro- and macrovascular complications in type 2 diabetes mellitus.

Increased oxidative stress in diabetes increases nitric oxide (NO) oxidation and low L-arginine (Arg) could further reduce NO and impair vascular function, thus accelerating, in the long run, vascular...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement